GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » Retained Earnings

Dis-Chem Pharmacies (JSE:DCP) Retained Earnings : R2,693 Mil (As of Aug. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Dis-Chem Pharmacies's retained earnings for the quarter that ended in Aug. 2023 was R2,693 Mil.

Dis-Chem Pharmacies's quarterly retained earnings increased from Aug. 2022 (R2,199 Mil) to Feb. 2023 (R2,355 Mil) and increased from Feb. 2023 (R2,355 Mil) to Aug. 2023 (R2,693 Mil).

Dis-Chem Pharmacies's annual retained earnings increased from Feb. 2021 (R1,368 Mil) to Feb. 2022 (R1,776 Mil) and increased from Feb. 2022 (R1,776 Mil) to Feb. 2023 (R2,355 Mil).


Dis-Chem Pharmacies Retained Earnings Historical Data

The historical data trend for Dis-Chem Pharmacies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies Retained Earnings Chart

Dis-Chem Pharmacies Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 344.89 717.82 1,368.48 1,776.31 2,354.84

Dis-Chem Pharmacies Semi-Annual Data
Feb14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,506.18 1,776.31 2,199.25 2,354.84 2,693.08

Dis-Chem Pharmacies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Dis-Chem Pharmacies  (JSE:DCP) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Dis-Chem Pharmacies (JSE:DCP) Business Description

Traded in Other Exchanges
N/A
Address
23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.